Biology of T lymphocytes

 
Principal Investigator :  Vineeta Bal

Project Associates / Assistants
Rashmi Sharma
Sangeeta Thatai

Ph D Students
A Rama Sundari
Anupriya Khare
Monika Vig (till Jun 2002)
Nagesh N Panday
Usha Kandpal

Collaborators
Anna George
Satyajit Rath
B Ravindran, RMRC, Bhubaneswar
Jeannine M Durdik, Univ Arkansas, USA
Jonathan R Lamb, Univ Edinburgh, UK

Analysis of effects of pharmacological agents on the activation of lymphocytes is the theme of research. The objectives of the project are to (i) study the role of modulators of intracellular reactive oxygen and nitrogen species in T lymphocyte responses, and (ii) analyse the effects of modulators of intracellular cAMP levels on T dependent and independent B cell responses.

To study the role of modulators of intracellular reactive oxygen and nitrogen species in T lymphocyte responses

Earlier we had reported that superoxide dismutase (SOD) mimetic, and peroxynitrite scavenger Mn (III) tetrakis (5,10,15,20-benzoic acid) porphyrin (MnTBAP), which protects T cells from superoxide generation enhances immune memory in vitro and in vivo by providing protection from cell death. Since presence of MnTBAP influences both the amount of reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) present in the cell, we undertook experiments to find out what roles ROI and RNI play in secondary T cell response enhancement. For this, we used human allo-recognition system in vitro. Peripheral blood mononuclear cells (PBMCs) from HLA-mismatched responder-stimulator donors were used. Responder T cells were primed in vitro with irradiated stimulator PBMCs in presence or absence of various pharmacological agents and the ability of primed T cells to respond to same allo-PBMCs was measured by tritiated thymidine incorporation as a secondary or memory response.

Glutathione decreases availability of ROI in the cell and does not directly affect RNI availability. Hence we used a cell permeable analogue of glutathione -glutathione monoethyl ester- during T cell priming. Unlike MnTBAP which enhances immune memory, priming in presence of glutathione monoethyl ester did not enhance the secondary response indicating that the role of MnTBAP as SOD and peroxidase mimic may not be significant in immune memory. Nitric oxide synthase (NOS) enzymes are the major contributors to the RNI in various cells. There are at least three types of NOS present in the body and we used a pan-NOS inhibitor L-NMMA during allo-priming. The T cells primed in presence of L-NMMA showed enhanced secondary response similar to one observed with MnTBAP. In order to identify which specific NOS might be contributing to the observed effect, we first used NOS2 (iNOS)-specific inhibitor aminoguanidine (AG) during T cell priming and it showed the same effect as observed with pan-NOS inhibitor. These data clearly indicated that NOS2 inhibition during T cell priming is responsible for enhanced secondary response and immune memory.

We had reported earlier that anti-CD3 mediated activation induced T cell death is retarded in presence of MnTBAP. We have used AG and L-NMMA in a similar assay and find that decrease in available RNI during T cell activation inhibits post activation T cell death.

We have also analysed the effects of ROI and RNI on mouse T cells. Presence of MnTBAP during allo-priming of mouse T cells results in enhanced secondary response as seen in human T cells. We have also validated the efficacy of MnTBAP to enhance immune memory when used during protein immunisation of mice. Since all these data suggest a major role for RNI in immune memory, we used NOS2null mice for dissecting the role of NOS2 in immune memory.

The ability of T cells from NOS2null (H-2b) mice to respond in vitro to allo-antigen presenting cells (APCs) from BALB/c (H-2d) mice was compared to C57BL.6 (Wild type, WT) mice. Primed NOS2null and WT cells were harvested and labeled with CFSE, a dye used routinely for monitoring cell divisions by flowcytometry. Irradiated BALB/c stimulators were used for secondary recall and the number of dividing cells was monitored from the two groups over 72-96 hours by flowcytometry. Our data show that T cells from NOS2null mice are present in larger numbers as compared to those from WT mice at the end of priming. However, the rate of cell division does not appear to be different between the two groups of primed T cells. Thus, the data show that priming results in larger number of cells in NOS2null mice as compared to WT mice. Whether the increased numbers of primed cells seen is due directly to absence of NOS2 in T cells leading to T cell survival remains to be confirmed.

To analyse the effects of modulators of intracellular cAMP levels on T dependent and independent B cell responses.

We have extensively characterised the effects of PF on T cell activation and death. Now we are attempting to see whether T-dependent and T-independent B cell responses can be influenced by PF and other mediators causing increase in intracellular cAMP levels.

We have used increasing doses of PF in splenocyte cultures stimulated with T-independent
stimulus - lipopolysaccharide (LPS) and analysed the effects on B cell proliferation and antibody secretion. Our data show that presence of PF inhibits both B cell proliferation as well as antibody secretion in a dose-dependent manner. When dibutyryl-cAMP, a cell permeable cAMP analogue with long half life, is used in a manner similar to PF, it also inhibited T-independent B cell proliferation and antibody secretion.

We next looked at the ability of PF to modulate T-dependent B cell responses. Our preliminary results show that while B cell proliferation brought about by allo-stimulus provided in the form of T cell help is partially inhibited in presence of PF in a dose-dependent manner, however, there is no significant inhibition of the antibody secretion.

Publications

Original peer-reviewed articles

1.     John B, Rajagopal D, Pashine A, Rath S, George A and Bal V (2002) Role of IL-12-independent and IL-12-dependent pathways in regulating generation of the IFN-g component of T cell responses to Salmonella typhimurium. J Immunol 169:2545-2552.

2.     Suresh R, Vig M, Bhatia S, Goodspeed EPB, John B, Kandpal U, Srivastava S, George A, Sen R, Bal V, Durdik JM and Rath S (2002) Pentoxifylline functions as an adjuvant in vivo to enhance T cell immune responses by inhibiting activation-induced death. J Immunol 169:4262-4272.

3.     Vig M, George A, Sen R, Durdik J, Rath S and Bal V (2002) Commitment of activated T cells to secondary responsiveness is enhanced by signals mediated by cAMP-dependent protein kinase A-I. Mol Pharmacol 62:1471-1481.

Reviews/Proceedings

1.     Bal V (2002) Gendered science: women as practitioners and as targets of research. Economic Political Weekly 37:5163-5167.